Standard BioTools Inc’s filing revealed that its Director Casdin Partners Master Fund, L acquired Company’s shares for reported $3669.0 on Mar 05 ’24. In the deal valued at $2.62 per share,1,403 shares were bought. As a result of this transaction, Casdin Partners Master Fund, L now holds 11,497,928 shares worth roughly $28.86 million.
Then, Casdin Partners Master Fund, L bought 250,000 shares, generating $642,500 in total proceeds. Upon buying the shares at $2.57, the Director now owns 11,496,525 shares.
Before that, Casdin Eli bought 800,000 shares. Standard BioTools Inc shares valued at $1,835,920 were divested by the Director at a price of $2.29 per share. As a result of the transaction, Casdin Eli now holds 1,200,000 shares, worth roughly $3.01 million.
TD Cowen initiated its Standard BioTools Inc [LAB] rating to a Buy in a research note published on April 16, 2024; the price target was $3.50. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early April with a ‘”a Buy”‘ rating. KeyBanc Capital Markets began covering LAB with “an Overweight” recommendation on July 12, 2023.
Price Performance Review of LAB
On Friday, Standard BioTools Inc [NASDAQ:LAB] saw its stock fall -0.79% to $2.51. Over the last five days, the stock has gained 2.87%. Standard BioTools Inc shares have risen nearly 13.57% since the year began. Nevertheless, the stocks have risen 67.33% over the past one year. While a 52-week high of $3.16 was reached on 04/09/24, a 52-week low of $1.46 was recorded on 01/05/24. SMA at 50 days reached $2.61, while 200 days put it at $2.43. A total of 1.61 million shares were traded, compared to the trading of 1.73 million shares in the previous session.
Levels Of Support And Resistance For LAB Stock
The 24-hour chart illustrates a support level at 2.46, which if violated will result in even more drops to 2.41. On the upside, there is a resistance level at 2.59. A further resistance level may holdings at 2.67. The Relative Strength Index (RSI) on the 14-day chart is 45.05, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.01, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 48.87%. Stochastics %K at 50.58% indicates the stock is a holding.
